VLA 0.00% $1.75 viralytics limited

Ann: CAVATAK anti-cancer activity - US Cancer Con, page-18

  1. 1,087 Posts.
    lightbulb Created with Sketch. 16
    re: Ann: CAVATAK anti-cancer activity - US Ca... Interesting post onaroll.... although I disagree. biotech is the hot sector for 2014... and BLT is up over 300% with no human testing what so ever, so i wouldn't rule out a good run for VLA. They have produced very promising results from their P1 and P2 trials and if you wait until they get their product to market or a takeover bid is put in, i think your chances of getting a multibagger or greatly diminished.

    I would also like to point out that BLT and VLA are comparable in their technology, the only comparisions between the two are they are both in biotech and have both done a substantial capital raising recently.

    The relevance of my comment is that BLT is already a multi bagger and hasn't started human testing. Vla has gone through 2 stages of human testing with excerellent results. You chose yourself if a multibagger is possible
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.